Sad news...
No magic bullet yet for ME/CFS
The outcome of a positive Rituximab trial for ME/CFS - possibly, finally, an FDA approved drug, relief for many, acceptance for this disease, increased research fund - would have been spectacular but Dr. Mella reported this week in Norway that the trial unfortunately failed.
We won't exactly how it failed until next year but the failure almost certainly means that Rituximab will not be the next FDA approved drug for ME/CFS.
That doesn't mean that Rituximab's role in ME/CFS is necessarily over, however. Read more about it in
http://simmaronresearch.com/2017/11/norwegian-rituximab-chronic-fatigue-syndrome-mecfs-trial-fails/
No magic bullet yet for ME/CFS
The outcome of a positive Rituximab trial for ME/CFS - possibly, finally, an FDA approved drug, relief for many, acceptance for this disease, increased research fund - would have been spectacular but Dr. Mella reported this week in Norway that the trial unfortunately failed.
We won't exactly how it failed until next year but the failure almost certainly means that Rituximab will not be the next FDA approved drug for ME/CFS.
That doesn't mean that Rituximab's role in ME/CFS is necessarily over, however. Read more about it in
http://simmaronresearch.com/2017/11/norwegian-rituximab-chronic-fatigue-syndrome-mecfs-trial-fails/
![ME/CFS lecture | Dr Nancy Klimas | 2011 [Chronic Fatigue Syndrome / SEID / New Zealand] - YouTube](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
